Evaluation of Home Based Assessments on Participants With DMD

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

October 13, 2022

Primary Completion Date

April 4, 2023

Study Completion Date

April 4, 2023

Conditions
Duchenne Muscular Dystrophy
Interventions
DEVICE

Wearable Device

The wearable device used in this study is an FDA 510(k) cleared Class II medical device designed to collect medical grade, clinical quality biometric, physiological and other electronic clinician outcome assessments data in a clinical trial setting. The system processes raw data into recognizable clinical metrics including vital signs, activity and posture classifications, surface electromyography (sEMG), and sleep metrics. The sensors are multi-modal, multilocation, rechargeable and reusable.

OTHER

Duchenne Video Assessment (DVA)

The DVA is a standardized tool that documents and assesses compensatory movement strategies as a marker of quality of movement.

Trial Locations (1)

02129

Solid Biosciences, Charlestown

All Listed Sponsors
lead

Solid Biosciences Inc.

INDUSTRY